161 related articles for article (PubMed ID: 26905925)
1. Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome.
Silva JD; de Oliveira GP; Samary Cdos S; Araujo CC; Padilha Gde A; Costa e Silva Filho F; da Silva RT; Einicker-Lamas M; Morales MM; Capelozzi VL; da Silva VM; Lima LM; Barreiro EJ; Diaz BL; Pelosi P; Silva PL; Garcia CS; Rocco PR
Cell Physiol Biochem; 2016; 38(2):821-35. PubMed ID: 26905925
[TBL] [Abstract][Full Text] [Related]
2. Tracheal acid or surfactant instillation raises alveolar surface tension.
Nguyen TL; Perlman CE
J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
[TBL] [Abstract][Full Text] [Related]
3. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
[TBL] [Abstract][Full Text] [Related]
4. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
[TBL] [Abstract][Full Text] [Related]
6. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
[TBL] [Abstract][Full Text] [Related]
7. Exogenous surfactant therapy for ARDS.
Maruscak A; Lewis JF
Expert Opin Investig Drugs; 2006 Jan; 15(1):47-58. PubMed ID: 16370933
[TBL] [Abstract][Full Text] [Related]
8. The effects of exogenous surfactant treatment in a murine model of two-hit lung injury.
Zambelli V; Bellani G; Amigoni M; Grassi A; Scanziani M; Farina F; Latini R; Pesenti A
Anesth Analg; 2015 Feb; 120(2):381-8. PubMed ID: 25502842
[TBL] [Abstract][Full Text] [Related]
9. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
Zuo YY; Veldhuizen RA; Neumann AW; Petersen NO; Possmayer F
Biochim Biophys Acta; 2008 Oct; 1778(10):1947-77. PubMed ID: 18433715
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary surfactant function following endotoxin: effects of exogenous surfactant treatment.
Picone A; Gatto LA; Nieman GF; Paskanik AM; Lutz C
Shock; 1996 Apr; 5(4):304-10. PubMed ID: 8721392
[TBL] [Abstract][Full Text] [Related]
12. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways.
Zhou E; Li Y; Wei Z; Fu Y; Lei H; Zhang N; Yang Z; Xie G
Int Immunopharmacol; 2014 Sep; 22(1):133-40. PubMed ID: 24975658
[TBL] [Abstract][Full Text] [Related]
13. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
[TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
15. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS.
Tegtmeyer FK; Möller J; Zabel P
Eur Respir J; 2002 Apr; 19(4):776-9. PubMed ID: 11999008
[TBL] [Abstract][Full Text] [Related]
17. Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.
Huang TK; Uyehara CF; Balaraman V; Miyasato CY; Person D; Egan E; Easa D
Lung; 2004; 182(1):15-25. PubMed ID: 14752669
[TBL] [Abstract][Full Text] [Related]
18. Lodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome.
Kesecioglu J; Schultz MJ; Haitsma JJ; den Heeten GJ; Lachmann B
Eur Respir J; 2002 May; 19(5):820-6. PubMed ID: 12030719
[TBL] [Abstract][Full Text] [Related]
19. The role of exogenous surfactant in the treatment of acute lung injury.
Lewis JF; Veldhuizen R
Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
[TBL] [Abstract][Full Text] [Related]
20. KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice.
Kinniry P; Pick J; Stephens S; Jain D; Solomides CC; Niven R; Segal R; Christofidou-Solomidou M
Pediatr Pulmonol; 2006 Oct; 41(10):916-28. PubMed ID: 16871629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
